Articles: chronic.
-
Non-Invasive VentilationSESSION TYPE: Slide PresentationsPRESENTED ON: Saturday, March 22, 2014 at 12:15 PM - 01:15 PMPURPOSE: Evaluation of non invasive ventilation (NIV) instituted for the first time in hospitalizations of patients with exacerbation of chronic obstructive pulmonary disease (COPD) associated with acute hypercapnic respiratory failure (AHRF) and its prognosis. ⋯ The following authors have nothing to disclose: Maria João Oliveira, Margarida Dias, Inês Franco, Sara CondeNo Product/Research Disclosure Information.
-
Bronchiectasis PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: Evaluate the characteristics of patients with chronic obstructive pulmonary disease (COPD) and bronchiectasis. ⋯ The following authors have nothing to disclose: Maria João Oliveira, Daniel Coutinho, Daniel Vaz, Maria do Céu BritoNo Product/Research Disclosure Information.
-
Symptoms of Respiratory Disease PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: FeNO (fractional exhaled nitric oxide) may help identify cases of NAEB (nonasthmatic eosinophilic bronchitis) or asthma. The aim of this study is to evaluate the utility of FeNO in the evaluation of chronic cough ⋯ The following authors have nothing to disclose: Vijo PouloseNo Product/Research Disclosure Information.
-
Infectious Disease Case Report Posters ISESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: Introduction- 65 y o M with preexisting CHF, with Ejection fraction 30%, COPD on medicines ramipril - 2.5 mg/d, eplerenone - 25 mg, aspirin and clopidogrel 75 mg, cardace- 6.25 mg, atorvastatin - 10 mg, isosorbide mononitrate 20 mg and Lasix 40 mg. ⋯ The following authors have nothing to disclose: Nabaneeta KhattarNo Product/Research Disclosure Information.
-
Slide PresentationsPRESENTED ON: Sunday, March 23, 2014 at 04:15 PM - 05:15 PMPURPOSE: The purpose of this study was to evaluated the effect of triple-combined long acting inhaled bronchodilator treatment with roflumilast and dual-combined long acting inhaled bronchodilator and single-long acting inhaled bronchodilator treatment on exacerbations in patients with severe and very severe chronic obstructive pulmonary disease(COPD). ⋯ The following authors have nothing to disclose: Alizamin Sadigov, Sakhavatdin Akhundov, Rovshan BagirovNo Product/Research Disclosure Information.